Mylan Recalls Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets

Consumers Contact  888-406-9305

Please find the Australian recall of Mylan <> Alphapharm, Mylan Australia Recalls DILART® and DILART®HCT (Valsartan) Tablets

 Mylan Initiates Voluntary Nationwide Recall of 15 Lots of Valsartan Tablets, USP, Amlodipine and Valsartan Tablets, USP, and Valsartan and Hydrochlorothiazide Tablets, USP, Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient.
Mylan is notifying its distributors and customers by letter and is arranging for return of all recalled products. Wholesalers, retailers and consumers that are in possession of recalled product should contact Stericycle at 1-888-406-9305 for the return of the recalled product. Normal business hours are Monday through Friday 8 a.m. to 5 p.m. EST.

Mylan N.V. (NASDAQ: MYL) today announced that its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide recall to the consumer level of select lots of Valsartan-containing products, including six lots of Amlodipine and Valsartan Tablets, USP (including the 5mg/160mg, 10mg/160mg, and 10mg/320mg strengths), seven lots of Valsartan Tablets, USP (including 40 mg, 80 mg, 160 mg, and 320 mg strengths), and two lots of Valsartan and Hydrochlorothiazide Tablets, USP 320mg/25mg strength.  These products are being recalled due to detected trace amounts of an impurity, N-nitrosodiethylamine (NDEA) contained in the API Valsartan, USP, manufactured by Mylan Laboratories Limited. NDEA is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen according to the International Agency for Research on Cancer (IARC).
The finished products are manufactured by Mylan Pharmaceuticals Inc. and Mylan Laboratories Limited. These batches were distributed in the U.S. between March 2017 and November 2018.

IKEA Recalls GLIVARP ExtendableDining Tables Due to Laceration Hazard

This recall involves IKEA GLIVARP extendable dining tables in white. The recalled tables have four steel legs and a glass table top with an extension that can be pulled out to the side. They measure about 29 inches tall by 49 inches long. The glass table top extension measures about 25 inches long. The supplier number (12003) is printed on a sticker on the underside of the table frame. “GLIVARP” and the IKEA logo are also printed on the sticker.

GLIVARP extendable dining tables Recall

Name of product: GLIVARP extendable dining tables

Hazard: The table’s glass extension leaf can detach and fall unexpectedly, posing a laceration hazard.

Remedy: Refund Replace

Recall date: November 27, 2018

Units: About 8,200 (in addition, about 1,500 were sold in Canada)

IKEA toll-free at 888-966-4532 anytime or online at www.ikea-usa.com and click on Press Room at the bottom of the page, then on Product Recalls at the top of the page for more information

GLIVARP Table